Asahi Kasei Bioprocess America and GeminiBio enter strategic partnership to advance application of Inline Buffer Formulation and streamline biopharmaceutical manufacturing processes

News

Dec 06, 2024
Asahi Kasei Bioprocess America and GeminiBio enter strategic partnership to advance application of Inline Buffer Formulation and streamline biopharmaceutical manufacturing processes

The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and speed to market.
• Costs for biopharmaceutical production can be significantly reduced, positively affecting the accessibility of medication for patients globally.
• This partnership will be a catalyst for innovation at both companies, driving new industry standards.